Comparing two whole-body skin imaging systems
Part of Cancer, Skin clinical trials.
This study compares two systems that take pictures of your whole skin to find melanoma early. You might qualify if you have a higher risk for melanoma, such as having had melanoma before, many moles, or a strong family history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You need to understand German well enough to give consent
- You must have at least one higher-risk factor for melanoma (like previous melanoma, many moles, or family history)
- You must be able to stand without support for 30 minutes
- You cannot have a pacemaker or be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device (Dermalyser) that estimates how thick a suspected melanoma is by analyzing a dermoscopy image. It may help doctors plan surgery without needing extra procedures.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This study tests a new PET imaging method that tracks how fat is used in the body, which may help find melanoma earlier. Healthy volunteers are needed to set a baseline for this new technique.
This study tests whether an artificial intelligence (AI) system can detect melanoma better by looking at 3D images of your skin. It may help find skin cancers earlier, especially if you have many moles.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
This study looks at diagnostic and prognostic factors in people who have suspicious pigmented skin lesions or melanoma that doctors are evaluating with surgery or tissue sampling. It may help improve how clinicians decide what the lesion is and what to expect over time.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.